Brokerages Set Surgery Partners Inc (SGRY) PT at $18.00

Shares of Surgery Partners Inc (NASDAQ:SGRY) have earned a consensus rating of “Hold” from the eight research firms that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $18.00.

Several research firms recently commented on SGRY. BidaskClub lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Tuesday, April 16th. Zacks Investment Research lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday. ValuEngine lowered shares of Surgery Partners from a “buy” rating to a “hold” rating in a research note on Thursday, February 7th. Finally, Stifel Nicolaus set a $12.00 target price on shares of Surgery Partners and gave the company a “hold” rating in a research note on Wednesday, May 8th.

SGRY stock traded down $0.17 on Friday, hitting $10.09. 374,000 shares of the company’s stock traded hands, compared to its average volume of 242,988. Surgery Partners has a 1-year low of $9.14 and a 1-year high of $19.50. The firm has a market cap of $515.53 million, a PE ratio of -4.12 and a beta of 2.47. The company has a debt-to-equity ratio of 2.20, a current ratio of 1.49 and a quick ratio of 1.56.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Wednesday, May 8th. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.39) by ($0.03). Surgery Partners had a negative net margin of 11.59% and a negative return on equity of 4.01%. The business had revenue of $416.80 million for the quarter, compared to analyst estimates of $421.41 million. During the same period in the prior year, the company earned ($0.26) earnings per share. The firm’s revenue for the quarter was up 1.3% on a year-over-year basis. As a group, sell-side analysts expect that Surgery Partners will post -0.59 earnings per share for the current year.

Several large investors have recently modified their holdings of the stock. Citigroup Inc. lifted its position in shares of Surgery Partners by 40.5% in the 1st quarter. Citigroup Inc. now owns 3,512 shares of the company’s stock valued at $40,000 after acquiring an additional 1,013 shares in the last quarter. Wells Fargo & Company MN lifted its position in shares of Surgery Partners by 3.7% in the 1st quarter. Wells Fargo & Company MN now owns 31,224 shares of the company’s stock valued at $352,000 after acquiring an additional 1,121 shares in the last quarter. Principal Financial Group Inc. lifted its position in shares of Surgery Partners by 9.5% in the 4th quarter. Principal Financial Group Inc. now owns 19,325 shares of the company’s stock valued at $189,000 after acquiring an additional 1,672 shares in the last quarter. BNP Paribas Arbitrage SA lifted its position in shares of Surgery Partners by 3.0% in the 1st quarter. BNP Paribas Arbitrage SA now owns 104,284 shares of the company’s stock valued at $1,176,000 after acquiring an additional 3,068 shares in the last quarter. Finally, California Public Employees Retirement System lifted its position in shares of Surgery Partners by 11.3% in the 4th quarter. California Public Employees Retirement System now owns 36,917 shares of the company’s stock valued at $361,000 after acquiring an additional 3,739 shares in the last quarter. Institutional investors and hedge funds own 96.33% of the company’s stock.

About Surgery Partners

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Featured Article: Gap Up Stocks

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.